Multiple sclerosis (MS) is caused by an uncontrolled immune response against self-antigens in the central nervous system. The autoreactive components in the immune system are usually controlled by regulatory T cells (T{reg}). Not surprisingly, deficits in the T{reg} compartment are associated to MS and the susceptibility of mice to develop experimental autoimmune encephalomyelitis (EAE), an experimental model of MS. Thus, the study of the molecular mechanisms controlling T{reg} differentiation is needed to understand MS pathology and identify new therapeutic targets;these studies, however, cannot be easily performed in mammals. Worms and flies have been useful in the identification of the mechanisms governing innate immunity, but invertebrates do not have T{reg}. We found that the zebrafish has an immune system that shares several features with its mammalian counterpart, including the genes driving T{reg} differentiation. In this application we will use mice and zebrafish to identify the molecular pathways that control T{reg} generation. This goal will be achieved by three independent approaches: 1. Bioinformatic identification of transcription factors controlling T{reg} differentiation. 2. High throughput screen to identify chemicals that regulate T{reg} differentiation. 3. Characterization of the role of the transcription factors and chemical compounds on T{reg} activity during the course of EAE. This project has the potential to identify therapeutic targets for the management of MS, and to establish the zebrafish as a platform for the high throughput identification of immunomodulatory drugs. In summary, this is an innovative project that will combine the experimental advantages offered by mice and zebrafish to identify pathways controlling T{reg} generation and is consistent with the aims of the New Pathway to Independence Award Program.
Studying the mechanisms that control immunoregulation is necessary to understand and identify new therapies for autoimmune disorders but these studies are not easily performed in mammals. We have found that immunoregulatory mechanisms similar to those found in mammals operate in the zebrafish. In this application we propose to perform investigations in mice and zebrafish (Danio rerio) as a model useful for the identification of compounds and signaling pathways that regulate the immune response.
| Gutiérrez-Vázquez, Cristina; Quintana, Francisco J (2018) Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity 48:19-33 |
| Rothhammer, Veit; Kenison, Jessica E; Tjon, Emily et al. (2017) Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. Proc Natl Acad Sci U S A 114:2012-2017 |
| Longhi, Maria Serena; Vuerich, Marta; Kalbasi, Alireza et al. (2017) Bilirubin suppresses Th17 immunity in colitis by upregulating CD39. JCI Insight 2: |
| Goettel, Jeremy A; Gandhi, Roopali; Kenison, Jessica E et al. (2016) AHR Activation Is Protective against Colitis Driven by T Cells in Humanized Mice. Cell Rep 17:1318-1329 |
| Rothhammer, Veit; Mascanfroni, Ivan D; Bunse, Lukas et al. (2016) Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 22:586-97 |
| Yeste, Ada; Takenaka, Maisa C; Mascanfroni, Ivan D et al. (2016) Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2. Sci Signal 9:ra61 |
| Caballero-Hernandez, Diana; Toscano, Miguel G; Cejudo-Guillen, Marta et al. (2016) The 'Omics' of Amyotrophic Lateral Sclerosis. Trends Mol Med 22:53-67 |
| Covacu, Ruxandra; Philip, Hagit; Jaronen, Merja et al. (2016) System-wide Analysis of the T Cell Response. Cell Rep 14:2733-44 |
| Mascanfroni, Ivan D; Takenaka, Maisa C; Yeste, Ada et al. (2015) Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-?. Nat Med 21:638-46 |
| Joller, Nicole; Lozano, Ester; Burkett, Patrick R et al. (2014) Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 40:569-81 |
Showing the most recent 10 out of 27 publications
